HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Henry J Riordan Selected Research

dimethylaminoethanol pyroglutamate

1/2012Effect of six months of treatment with V0191 in patients with suspected prodromal Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Henry J Riordan Research Topics

Disease

1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2021
1Frontotemporal Dementia (Semantic Dementia)
01/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2012
1Hyperglycemia
09/2011
1Schizophrenia (Dementia Praecox)
09/2011
1Weight Gain
09/2011
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2011
1Mental Disorders (Mental Disorder)
06/2011

Drug/Important Bio-Agent (IBA)

1cyclo(Arg-Pro) (CI 4)IBA
01/2021
1ProgranulinsIBA
01/2021
1Histone Deacetylase InhibitorsIBA
01/2021
1dimethylaminoethanol pyroglutamateIBA
01/2012
1Antipsychotic Agents (Antipsychotics)IBA
09/2011
1Triglycerides (Triacylglycerol)IBA
09/2011
1Glucose (Dextrose)FDA LinkGeneric
09/2011
1Varenicline (Chantix)FDA Link
06/2011